Genmab — Februar 2016
-
Tisotumab Vedotin for at få det hele med...
-
-
Medwatch har ændret deres overskrift. De læser selvfølgelig med her som vanligt.
-
mon ikke vi kan regne med, at der kommer lidt medvind med al den omtale af den gode darzalex launch - det må tage toppen af usikkerheden
-
highly realistic at nå darzalex guidiance jf. Eatwell på baggrund af det de har set hidtil
-
Han snakker om sizebale milestone for Dara i 2017 !! Nok baseret på salgsmilestones
-
castor pollux i H1
-
godot i H2
-
var det tf-adc i H2?
-
ja
-
nok på ASH
-
Fantastisk.
-
lyder som om SGEN opt-in beslutningen kommer i løbet af 2016
-
Stort stigende salg i januar.
-
robust pick-up in January - Dara uptake
-
week on week growth
-
2016 modelleret på krypolis og pomalyst intro'er
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind